Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study-Reference-Cited by-同舟云学术

Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study

Published:2016-10-14 Issue: Volume: Page:ehw496
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Staerk Laila,Fosbøl Emil Loldrup,Lip Gregory Y.H.,Lamberts Morten,Bonde Anders Nissen,Torp-Pedersen Christian,Ozenne Brice,Gerds Thomas Alexander,Gislason Gunnar Hilmar,Olesen Jonas Bjerring

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/38/12/907/11078243/ehw496.pdf

Reference22 articles.

1. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

2. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

3. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

4. Stroke Prevention in Atrial Fibrillation

5. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation;International Journal of Cardiology;2024-06

2. Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation;Scientific Reports;2024-04-29

3. Thromboembolic events after major bleeding events in patients with mechanical heart valves: a 13-year analysis;Journal of Thrombosis and Thrombolysis;2024-03-31

4. Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making;Drug Safety;2024-03-06

5. Chronic Kidney Disease is a Predictor of Recurrent Bleeding in Patients With Atrial Fibrillation After Resuming Anticoagulant Therapy (based on REGistry of Long-term AnTithrombotic TherApy (REGATA-2);Kardiologiia;2023-11-08